CMS increases MUE for Harrow's IHEEZO J-Code from 1 to 2, effective July 2024 retroactive to Jan 1, 2024

HARROW, INC.

CMS approved increase of Medically Unlikely Edit (MUE) for IHEEZO J-Code J2403 from 1 to 2 units.
Change allows billing for two vials of IHEEZO, supporting bilateral ocular procedures.
Effective July 2024, with retroactive application to procedures from January 1, 2024.
Company requested the change in February 2024 citing ophthalmologist need for bilateral use.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.